Imbio RV/LV Software vs AVIEW Lung Nodule CAD
AI Verdict
Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if your primary need is rapid, automated assessment of right ventricular strain in patients undergoing CTPA scans, particularly for suspected pulmonary embolism. This tool is ideal for emergency departments and critical care settings requiring quick risk stratification based on the RV/LV ratio to guide immediate patient management.
View Imbio RV/LV Software →Choose AVIEW Lung Nodule CAD if…
Choose AVIEW Lung Nodule CAD if your institution requires a comprehensive AI solution for lung cancer screening programs and the simultaneous assessment of other significant pulmonary and cardiovascular conditions. This tool excels in detecting and characterizing lung nodules, tracking their progression over time, and providing quantitative analysis for emphysema and coronary artery calcification from a single chest CT.
View AVIEW Lung Nodule CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio RV/LV Software | AVIEW Lung Nodule CAD |
|---|---|---|
| Deployment | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] | On-premises and cloud environment |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio RV/LV SoftwareTool A explicitly highlights a 'fully automated workflow, no user intervention required after scan completion' and 'integration with standard reading environments (PACS)'. While Tool B also implies automation with report generation, Tool A's detailed description of seamless integration and minimal user interaction suggests a slightly higher emphasis on out-of-the-box usability for its specific function.
Clinical Value
AVIEW Lung Nodule CADTool B offers a broader and more comprehensive set of clinical insights by simultaneously analyzing lung nodules, emphysema, and coronary artery calcification (the 'Big 3'). It provides detailed quantification, classification, and follow-up capabilities for these multiple critical conditions. While Tool A is highly valuable for its specific use case in PE risk stratification, Tool B's wider diagnostic and prognostic scope provides greater overall clinical value from a single scan.
Pricing & Value
Imbio RV/LV SoftwareTool A provides a clearer pricing model, stating it is 'subscription-based' and 'Based on number of analyses, number of installations'. This offers more transparency upfront, allowing potential customers to better understand and estimate costs. Tool B's pricing is 'not publicly disclosed', requiring direct contact for information, which makes an initial assessment of value more challenging.
Enterprise Readiness
Imbio RV/LV SoftwareBoth tools offer flexible deployment options and are FDA cleared and HIPAA compliant. However, Tool A specifically mentions 'third-party hipaa compliant certified by compliancy group' and lists integration with numerous 'partner platforms' (e.g., Nuance, Aidoc, Siemens Syngo.via), indicating a more robust and proven ecosystem for enterprise-level deployment and integration within existing healthcare IT infrastructures.
Innovation
AVIEW Lung Nodule CADWhile both leverage AI, Tool B demonstrates a broader range of innovative features by simultaneously analyzing multiple distinct conditions (lung nodules, emphysema, and coronary artery calcification) from a single CT scan. Its capabilities include detailed nodule classification, 3D volume quantification, VDT calculation for follow-up, and comprehensive CAC scoring, showcasing a more expansive application of AI for multi-faceted diagnostic insights.
Support & Docs
TieThe provided structured facts do not contain specific details regarding the level, availability, or type of support and documentation for either Tool A or Tool B. Without further comparable information on aspects like 24/7 support, online knowledge bases, or dedicated account management, it is not possible to distinguish between the two offerings in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio RV/LV Software | AVIEW Lung Nodule CAD |
|---|---|---|
| Primary AI Focus | Automated measurement of right and left ventricular diameters, calculation and reporting of RV/LV ratio from CTPA scans. | AI-based pulmonary nodule detection (3-20 mm), nodule classification, 3D nodule size and volume quantification, simultaneous analysis of lung nodules, emphysema, and coronary artery calcification. |
| Company | Imbio | Coreline Soft Co. |
| Supported Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
| Key Reporting/Output | Annotated images showing ventricular measurements, summary PDF reports. | Automatic report generation based on Lung-RADS classification, nodule matching and volume doubling time (VDT) calculation, quantitative emphysema analysis, Coronary Artery Calcification (CAC) scoring. |
Videos
Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and AVIEW Lung Nodule CAD.